ACC 2023

Latest ACC 2023 News

HOST-IDEA: 3-Month DAPT Noninferior to 12-Month DAPT in Patients Undergoing PCI using third-generation stents

Key Points: Among patients undergoing PCI using third-generation DES with ultrathin struts…

Leah Kosyakovsky

UK Biobank Analysis: Self-reported LCHF Diet May be Linked to Cardiac Events

Key Points: In spite of the increase popularity of low-carbohydrate high-fat diet…

Leah Kosyakovsky

hsCRP is a Stronger Predictor of CV Events and Death than LDL-C in High-Risk Patients on Statins

Key Points: Both inflammatory risk and hyperlipidemia and crucial risk factors for…

Leah Kosyakovsky

FREEDOM COVID: Therapeutic dose anticoagulation does not reduce MACE in non-critically ill COVID-19 patients

Key Points: There have been conflicting data on the role and recommended…

Leah Kosyakovsky

STELLAR: Sotatercept improves 6MWD in PAH patients and WHO FC II-III

Key Points: Sotatercept is a novel activin signaling inhibitor which was designed…

Leah Kosyakovsky

Dapagliflozin Reduces PCWP at Rest and Exercise, Plasma Volume, and Weight in HFpEF patients

Key Points: SGLT2i therapy reduces HF hospitalizations and CV mortality in HFpEF,…

Leah Kosyakovsky

The future is now: A wrist-worn Sensor Coupled with AI Accurately Predicts Troponin Elevation in ACS Patients

Key Points - Prompt identification of patients suffering from ACS requires measurements…

Leah Kosyakovsky

Low Cardiac Risk for Elite Level Athletes With Genetic Heart Disease

Key Points -Patients with diagnosed sudden cardiac death (SCD)-predisposing genetic heart diseases…

Leah Kosyakovsky

Macitentan/Tadalafil Fixed Dose Combination reduces PVR compared with monotherapy

Key Points: Macitentan and Tadalfil are frequently used in combination for PAH,…

Leah Kosyakovsky

A Virtual Care Team-Guided Strategy Improved GDMT in Hospitalized HFrEF Patients: the IMPLEMENT-HF Study

Key Points Despite an extensive body of evidence supporting the benefit and…

Leah Kosyakovsky

Lifelong Endurance Not linked to Favorable Coronary Plaque Composition but Less Vulnerable ones: MASTER at HEART Trial

Key Points Cardiovascular risk mitigation strategies such as the recommendation to engage…

Leah Kosyakovsky

Treat-to-target LDL Strategy Non-inferior to High-Intensity Statin Therapy In CAD Patients: the LODESTAR trial

Key Points Appropriate lipid management is of critical importance in preventing further…

Leah Kosyakovsky

Black women with TTR V122I variant have higher risk of CVD and all-cause mortality

Key Points:  The prognostic significance of the V122I variant (associated with…

Leah Kosyakovsky

The Final Word on Transcatheter edge-to-edge Repair with MitraClip– COAPT Five Year Results

Key Points: Two-year results showed improved outcomes with the MitraClip device but…

Leah Kosyakovsky

Pulsed Field Ablation Effective to treat Paroxysmal and Persistent AF: The PULSED AF Pivotal Trial

Key Points: - Pulsed field ablation (PFA) is a novel ablation technology…

Leah Kosyakovsky

COORDINATE-Diabetes – A Coordinated, Multifaceted Intervention Increases Prescription of Evidence-based Therapies for Adults with T2D and CV Disease

Key Points Evidence-based therapies that reduce cardiovascular risk remain underused among individuals…

Leah Kosyakovsky

The GCCF Project: Remote monitoring reduces cardiology’s carbon footprint

Key Points Cardiac device monitoring is a repetitive, long term activity that…

Leah Kosyakovsky